Evidence map›Paper›PMID 31299904›Full record

ArticleBMC microbiology2019

Molecular characteristics of oxazolidinone resistance in enterococci from a multicenter study in China.

Hongbin Chen, Xiaojuan Wang, Yuyao Yin, Shuguang Li, Yawei Zhang, Qi Wang, Hui Wang

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in BMC microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 35 citations in OpenAlex.

  1. Linezolid in the Focus of Antimicrobial Resistance ofInternational journal of molecular sciences · 2025
    Review
  2. Article
  3. Antibiotics and Bacterial Resistance-A Short Story of an Endless Arms Race.International journal of molecular sciences · 2023
    Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Prevalence and Characteristics of Phenicol-Oxazolidinone Resistance Genes inInternational journal of molecular sciences · 2021
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Resistance in Vancomycin-Resistant Enterococci.Infectious disease clinics of North America · 2020
    Review
  14. Article
  15. Comparative genomics of globalMicrobial genomics · 2020
    Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Hongbin ChenDepartment of Clinical Laboratory, Peking University People's Hospital, Beijing, 100044, People's Republic of China.
Xiaojuan WangDepartment of Clinical Laboratory, Peking University People's Hospital, Beijing, 100044, People's Republic of China.
Yuyao YinDepartment of Clinical Laboratory, Peking University People's Hospital, Beijing, 100044, People's Republic of China.
Shuguang LiDepartment of Clinical Laboratory, Peking University People's Hospital, Beijing, 100044, People's Republic of China.
Yawei ZhangDepartment of Clinical Laboratory, Peking University People's Hospital, Beijing, 100044, People's Republic of China.
Qi WangDepartment of Clinical Laboratory, Peking University People's Hospital, Beijing, 100044, People's Republic of China.
Hui WangDepartment of Clinical Laboratory, Peking University People's Hospital, Beijing, 100044, People's Republic of China. whuibj@163.com.ORCID 0000-0001-9220-0357
Peking University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLinezolid-resistant enterococci pose great challenges in clinical practice. The aim of this study is to study the mechanisms underlying the resistance and genetic environment of antimicrobial resistance gene of linezolid-resistant enterococci.

resultsThe linezolid MICs of 16 enterococci were 4 mg/L to 16 mg/L. Four strains belonged to multi-drug resistant (MDR) bacteria. The sequence types (STs) of 13 enterococci strains performed WGS were diverse: 3 ST476, 1 ST86, ST116, ST480, ST59, ST416, ST21, ST67, ST16, ST585 and ST18. None of them carried multi-drug resistance gene cfr. Only one strain had the G2658 T mutation of target 23S rRNA gene. Thirteen (13/16, 81.3%) strains harbored the novel oxazolidinone resistance gene optrA. WGS analysis showed that the optrA gene was flanked by sequence IS1216E insertion in 13 strains, and optrA was adjacent to transposons Tn558 in two strains and Tn554 in one strain. The optrA gene was identified to be co-localized with fexA, the resistance genes mediated florfenicol resistance in 13 strains, and ermA1, the resistance genes mediated erythromycin resistance in 9 strains, indicating that linezolid-resistant strains may be selected due to non-oxazolidinone antibiotics (i.e. macrolides and florfenicol) usage.

conclusionOur findings demonstrate the high diversity of optrA-carrying genetic platforms. The mobile genetic elements (MGEs) may play an important role in the dissemination of optrA into the enterococci isolates of human origin. The genetic evidence of transferable feature and co-selection of optrA should be gave more attention in clinical practice.

Indexed as

Enterococcus faecalisEnterococcus faeciumChinaDNA, BacterialDrug Resistance, Multiple, BacterialGenes, BacterialGram-Positive Bacterial InfectionsHumansLinezolidDNA, BacterialLinezolidEnterococciGenetic environmentLinezolid resistanceoptrAOxazolidinone

Identifiers

PMID31299904
PMCPMC6626368
OpenAlexW2956817510

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.